Cargando…
Correction: The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice
Autores principales: | Bae, Cho-Rong, Zhang, Haiying, Kwon, Young-Guen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021174/ https://www.ncbi.nlm.nih.gov/pubmed/33819305 http://dx.doi.org/10.1371/journal.pone.0249747 |
Ejemplares similares
-
The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice
por: Bae, Cho-Rong, et al.
Publicado: (2020) -
CU06-1004 (endothelial dysfunction blocker) ameliorates astrocyte end-feet swelling by stabilizing endothelial cell junctions in cerebral ischemia/reperfusion injury
por: Kim, Dong Young, et al.
Publicado: (2020) -
Long-term administration of CU06-1004 ameliorates cerebrovascular aging and BBB injury in aging mouse model
por: Kim, Hyejeong, et al.
Publicado: (2023) -
Efficacy of CU06-1004 via regulation of inflammation and endothelial permeability in LPS-induced acute lung injury
por: Kim, Yeomyeong, et al.
Publicado: (2023) -
CU06-1004 Alleviates Experimental Colitis by Modulating Colonic Vessel Dysfunction
por: Kim, Ye-Seul, et al.
Publicado: (2020)